| Albert Macdade, | |
|
2642 Enid Pl, Fort Smith, AR 72901-7128 | |
| (479) 646-5560 | |
| Not Available |
| Full Name | Albert Macdade |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 2642 Enid Pl, Fort Smith, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225185788 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | C5013 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Albert Macdade, 2642 Enid Pl, Fort Smith, AR 72901-7128 Ph: () - | Albert Macdade, 2642 Enid Pl, Fort Smith, AR 72901-7128 Ph: (479) 646-5560 |
News Archive
Neuroscientists studying the link between poor sleep and schizophrenia have found that irregular sleep patterns and desynchronised brain activity during sleep could trigger some of the disease's symptoms. The findings, published in the journal Neuron, suggest that these prolonged disturbances might be a cause and not just a consequence of the disorder's debilitating effects.
Patients who use anti-depressants are much more likely to suffer relapses of major depression than those who use no medication at all, concludes a McMaster researcher.
Alexion Pharmaceuticals, Inc. has announced today that Soliris® (eculizumab), its first-in-class complement inhibitor, has been granted Orphan Medicinal Product Designation by the European Commission for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). AHUS is an ultra-rare, inherited, and life-threatening complement-inhibitor deficiency disease that often progresses to end-stage kidney disease or failure. The U.S. Food and Drug Administration granted orphan drug designation to Soliris for the same indication in May 2009. Soliris is not approved for the treatment of patients with aHUS.
NUT midline carcinoma (NMC) is a cancer without a cure, and one that affects all age groups. NMC is a rapid-growth disease with an average survival time of four and a half months after diagnosis, making the development of clinical trials for potential therapies or cures for this cancer difficult, to say the least.
On April 29, 2011, Mediaplanet Publishing released a Kidney Health report to targeted markets in USA Today. The report will be distributed to 1 million readers with contributions from Kidney Cancer Association, National Kidney Foundation, Fresenius Medical Care North America, UKidney, Medical Education Institute, and National Kidney Registry.
› Verified 7 days ago
Dr. Arthur M Johnson, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 Dodson Ave Ste 290, Fort Smith, AR 72901 Phone: 479-709-7175 Fax: 479-709-7180 | |
Adam Michael Olszewski, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 7001 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-2370 Fax: 479-274-2380 | |
Jessica Marie Kopacz, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 7001 Rogers Ave Ste 501, Fort Smith, AR 72903 Phone: 479-573-3101 Fax: 479-573-3102 | |
Timothy Y. Maryanov, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9616 Rogers Ave, Fort Smith, AR 72903 Phone: 479-242-3310 Fax: 479-439-8868 | |
Dr. Joseph William Queeney, D.O. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3501 We Knight Dr, Fort Smith, AR 72903 Phone: 479-709-6700 Fax: 479-709-6709 |